Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.31 CHF | -0.77% | +4.45% | +5.27% |
08:14am | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.27% | 201B | |
+25.11% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+12.68% | 233B | |
-10.31% | 193B | |
-12.26% | 143B | |
-6.47% | 144B | |
+0.23% | 123B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis' : Iptacopan Shows Positive Results in Rare Blood Disorder Patients